Vocal Biomarkers Market to Surpass US$ 9 Billion by 2032, Projects Fact.MR

Voice biomarkers market would be worth US$ 2.3 billion in 2023. By 2033, it is anticipated to hit US$ 9.1 billion. The demand for vocal biomarkers is anticipated to grow globally between 2023 and 2033 at a CAGR of 14.7%.

Over the next ten years, there will likely be a major increase in the market for voice biomarkers. The increase in neurological, mental, and other language-related diseases may be to blame for this.

Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=719?AS

Market Frontrunners

• Boston Technology Corporation
• EVOCAL Health
• Audio Profiling
• Cogito Corporation
• Kintsugi
• Sharecare Inc.
• Microtest Health
• Sonde Health
• AudEERING
• Beyond Verbal
• IBM Corporation

Key Drivers

• North America is likely to capture a commendable share of the global vocal biomarker market.
• Europe will exhibit strong growth on the back of expanding psychiatrist clinics, presence of leading players, and advancement in medical technology across the U.K. and Germany.
• With increasing prevalence of cardiovascular and psychological disorders and rising government support, Asia is expected to emerge as a lucrative market for vocal biomarkers.
• By indication, psychiatric disorders segment is expected to dominate the vocal biomarker market.
• Hospitals & clinics segment will emerge as the primary end user in the global vocal biomarker market.
• Increasing prevalence of psychological and cardiovascular disorders worldwide is driving the vocal biomarker market.
• Rising need for minimally invasive procedures for diagnosis of various disorders will continue to fuel the demand for vocal biomarkers.
• Low cost, easy availability, and growing awareness regarding the importance of vocal biomarkers will aid the growth in the market during the forecast period.
• Emergence of advanced vocal biomarker screening platforms will facilitate the growth in the market.

Recent Developments

• In August 2022, PureTech Health plc announced that its founding company, Sonde Health has entered into a multi-year agreement with pharmaceutical company Koye Pharmaceuticals. This agreement will help the company to develop novel voice biomarker detection and monitoring capabilities for chronic obstructive pulmonary disease (COPD) in India.
• In August 2022, Ellipsis Health and Ceras Health, a leading digital health solutions company, joined hands to accelerate the former's discovery in using the human voice as a mental biomarker.

Segment Insights

With the modern study, Fact.MR provides an unbiased analysis of the global vocal biomarker market over the forecast period (2023 to 2033). The study also provides a comprehensive analysis of key trends, opportunities, and drivers driving the sales of vocal biomarkers through detailed segmentation as follows:

Technique:
• Frequency
• Amplitude
• Error Rate
• Vocal Rise or Fall Time
• Phonation Time
• Vocal Tremor
• Pitch
• Others

Indication:
• Psychiatric Disorders
• Respiratory Disorders
• Cardiovascular Disorders
• Traumatic Brain Injury (TBI)
• Neurological disorders
• Other

End User:
• Hospitals & Clinics
• Contract Research Organizations CROs)
• Academic & Research Centers
• Other End Users

Region:
• North America
• Latin America
• Europe
• Asia and Pacific
• The Middle East and Africa

Key Questions Covered in the Vocal Biomarker Market Report

• How will the demand for vocal biomarkers surge during the forecast period?
• Which are the key trends propelling the sales of a vocal biomarker in the market?
• Which region will be the most lucrative in the vocal biomarker market from 2023 to 2033?
• What is the projected market valuation of the vocal biomarker market in 2033?
• What are the challenges vocal biomarker providers might face over the upcoming decade?
• Which will be the leading end users in the vocal biomarker market?

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=719?AS

Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Email : sales@factmr.com

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. We are committed to deliver insights that help businesses gain deeper understanding of their target markets. We understand that making sense of the vast labyrinth of data can be overwhelming for businesses. That's why focus on offering insights that can actually make a difference to bottom-lines.

This release was published on openPR.